Teacher Retirement System Of Texas Fibrogen Inc Transaction History

Teacher Retirement System Of Texas

$20.2 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 19, 2023	SELL	$2.49 - $20.59 $8,022 - $66,340	-3,222 Reduced 11.72%	24,274 $66,000
Q1 2023 May 12, 2023	BUY	$15.95 - $25.18 $7,512 - $11,859	471 Added 1.74%	27,496 $513,000
Q4 2022 Feb 10, 2023	SELL	$13.27 - $17.73 $27,721 - $37,037	-2,089 Reduced 7.18%	27,025 $433,000
Q3 2022 Nov 03, 2022	BUY	$11.4 - $14.6 $180,028 - $230,563	15,792 Added 118.54%	29,114 $379,000
Q2 2022 Aug 09, 2022	SELL	$7.94 - $12.96 $30,854 - $50,362	-3,886 Reduced 22.58%	13,322 $141,000
Q1 2022 May 09, 2022	BUY	$12.02 - $16.79 $14,099 - $19,694	1,173 Added 7.32%	17,208 $207,000
Q4 2021 Feb 10, 2022	BUY	$9.93 - $15.39 $28,290 - $43,846	2,849 Added 21.61%	16,035 $226,000
Q3 2021 Nov 09, 2021	BUY	$10.18 - $26.64 $26,641 - $69,716	2,617 Added 24.76%	13,186 $135,000
Q2 2021 Aug 05, 2021	BUY	$18.57 - $35.68 $29,786 - $57,230	1,604 Added 17.89%	10,569 $281,000
Q1 2021 May 11, 2021	BUY	$31.0 - $55.72 $51,677 - $92,885	1,667 Added 22.84%	8,965 $311,000
Q4 2020 Feb 11, 2021	BUY	$37.09 - $48.97 $270,682 - $357,383	7,298 New	7,298 $271,000
Q4 2018 Mar 04, 2019	SELL	$37.97 - $60.16 $335,920 - $532,235	-8,847 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$56.3 - $67.25 $351,537 - $419,909	-6,244 Reduced 41.38%	8,847 $537,000
Q2 2018 Aug 06, 2018	SELL	$44.9 - $64.95 $12,123 - $17,536	-270 Reduced 1.76%	15,091 $945,000
Q1 2018 May 08, 2018	SELL	$45.35 - $61.65 $336,769 - $457,812	-7,426 Reduced 32.59%	15,361 $710,000
Q4 2017 Feb 06, 2018	BUY	$41.95 - $60.1 $722,546 - $1.04 Million	17,224 Added 309.62%	22,787 $1.08 Million
Q3 2017 Nov 06, 2017	BUY	$33.4 - $53.9 $185,804 - $299,845	5,563	5,563 $299,000

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $31.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.

Account